| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $76.2M | -44.8% |
| R&D Expense | $68.7M | -17.6% |
| SG&A Expense | $29.8M | +0.4% |
| Operating Income | -$22.4M | -189.5% |
| Pre-tax Income | -$17.1M | -153.4% |
| Income Tax | $238K | +6.3% |
| Net Income | -$17.4M | -154.5% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $12.7M | -66.7% |
| Accounts Receivable | $2.0M | -35.1% |
| Current Assets | $143.9M | +34.1% |
| Total Assets | $151.6M | +25.7% |
| Current Liabilities | $46.6M | -45.7% |
| Total Liabilities | $52.6M | -56.6% |
| Stockholders' Equity | $99.0M | — |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$75.6M | +12.3% |
| Capital Expenditures | $220K | -29.0% |
| Investing Cash Flow | -$59.7M | -159.9% |
| Financing Cash Flow | $110.4M | +1368.3% |
| Free Cash Flow | -$75.8M | +12.4% |